Kite Pharma Announces Exclusive License with The National Institutes of Health for T Cell Receptor (TCR)-Based Products Targeting NY-ESO-1 For Multiple Cancer Indications - KTUL.com - Tulsa, Oklahoma - News, Weather & Sports

Kite Pharma Announces Exclusive License with The National Institutes of Health for T Cell Receptor (TCR)-Based Products Targeting NY-ESO-1 For Multiple Cancer Indications

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Kite Pharma, Inc.

SANTA MONICA, Calif., June 6, 2014 /PRNewswire/ -- Kite Pharma, Inc., a clinical-stage biotechnology company focused on developing engineered autologous T cell therapy (eACT™) products for cancer, today announced that it has entered into an exclusive, worldwide license with the National Institutes of Health (NIH) to certain intellectual property related to T Cell Receptor (TCR)-based product candidates that target the NY-ESO-1 antigen for the treatment of cancers expressing NY-ESO-1.

Kite Pharma, Inc.'s logo

TCR product candidates are designed to recognize antigens irrespective of their cellular localization and as presented by the major histocompatibility complex (MHC) on the tumor cell.  The NY-ESO-1 antigen may be expressed in numerous tumor types, including sarcoma, bladder cancer, esophageal carcinoma, non-small cell lung cancer, breast carcinoma, ovarian carcinoma, prostate carcinoma, multiple myeloma, hepatocellular carcinoma and melanoma, among other tumor types.

The National Cancer Institute (NCI) is currently conducting a Phase 2 clinical trial of a murine TCR product candidate targeting the NY-ESO -1 antigen at the NIH pursuant to a Cooperative Research and Development Agreement (CRADA) between Kite and the NCI.  Kite is investigating murine (mouse)-derived TCR technology platforms developed by the NCI Surgery Branch for the treatment of solid tumors under the CRADA.  Preclinical evaluation in the Surgery Branch of murine TCRs targeting the NY-ESO-1 antigen identified a murine TCR with comparable or enhanced activity relative to the equivalent human-based NY-ESO-1 TCR.

Pursuant to the terms of the license agreement, Kite will make certain clinical, regulatory and sales milestone payments to the NIH.  In addition, Kite shall pay the NIH royalties on net sales of products covered by the license.

About Kite Pharma

Kite Pharma, Inc. is a privately held clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on eACT™ designed to restore the immune system's ability to recognize and eradicate tumors.  In partnership with the NCI Surgery Branch through a Cooperative Research and Development Agreement (CRADA), Kite is advancing a pipeline of proprietary eACT™ product candidates, both CAR (chimeric antigen receptor) and TCR (T cell receptor) products, directed to a wide range of cancer indications.  Kite's management team has a proven track record of building successful biotechnology companies and successfully developing novel immunotherapies and other oncology treatments.  Kite is based in Santa Monica, CA.

Kite Contact:

Cynthia M. Butitta
Chief Financial Officer and Chief Operating Officer
310-824-9999

For Media: Justin Jackson
For Investor Inquiries: Kimberly Minarovich
Burns McClellan
(212) 213-0006
jjackson@burnsmc.com
kminarovich@burnsmc.com

Logo - http://photos.prnewswire.com/prnh/20130513/MM13332LOGO

©2012 PR Newswire. All Rights Reserved.

  • NewsMore>>

  • Deadly Crash Shuts Down Highway 75 in West Tulsa

    Deadly Crash Shuts Down Highway 75 in West Tulsa

    Northbound lanes of Highway 75 were closed at the beginning of the morning rush hour early Friday after a deadly crash hours earlier.Drivers were being detoured at the 41st street exit. Tulsa Police say a 27-year-old man was thrown from his pickup truck when he went off the road, crashed into a guardrail and rolled down an embankment.The accident happened just after 12:45 a.m. north of 41st street.Witnesses at the scene told police they saw the truck speeding and driving erratically just befo...More >>
    Northbound lanes of Highway 75 were closed at the beginning of the morning rush hour early Friday after a deadly crash hours earlier.Drivers were being detoured at the 41st street exit. Tulsa Police say a 27-year-old man was thrown from his pickup truck when he went off the road, crashed into a guardrail and rolled down an embankment.The accident happened just after 12:45 a.m. north of 41st street.Witnesses at the scene told police they saw the truck speeding and driving erratically just befo...More >>
  • OKC Police Officer in Custody for Sexual Misconduct

    OKC Police Officer in Custody for Sexual Misconduct

    An Oklahoma City police officer has been accused of sexual misconduct and taken into custody.OKC police officer Daniel Holtzclaw was taken into custody earlier this afternoon in front of a Gold's Gym.Holtzclaw is accused of requiring women to expose themselves and perform sexual acts. He has been booked in the Oklahoma County jail on multiple charges, including rape, rape by instrumentation, forcible sodomy and sexual battery charges.Holtzclaw bond is set at five million dollars.More >>
    An Oklahoma City police officer has been accused of sexual misconduct and taken into custody.OKC police officer Daniel Holtzclaw was taken into custody earlier this afternoon in front of a Gold's Gym.Holtzclaw is accused of requiring women to expose themselves and perform sexual acts. He has been booked in the Oklahoma County jail on multiple charges, including rape, rape by instrumentation, forcible sodomy and sexual battery charges.Holtzclaw bond is set at five million dollars.More >>
  • NASCAR Sprint Cup Race At Bristol To Air On Alternate Channels In Tulsa Area

    NASCAR Sprint Cup Race At Bristol To Air On Alternate Channels In Tulsa Area

    Due to Tulsa Channel 8's live airing of the St. Louis Rams preseason game against the Cleveland Browns on Saturday, August 23, the schedule NASCAR Sprint Cup race at Bristol will be moved to alternate channels as follows:Over the air--KTUL 8.3 Cox Cable---131 DISH DirecTV---ESPN Alternate Channels DISH---channel 145 DirecTV---channel 209-1More >>
    Due to Tulsa Channel 8's live airing of the St. Louis Rams preseason game against the Cleveland Browns on Saturday, August 23, the schedule NASCAR Sprint Cup race at Bristol will be moved to alternate channels as follows:Over the air--KTUL 8.3 Cox Cable---131 DISH DirecTV---ESPN Alternate Channels DISH---channel 145 DirecTV---channel 209-1More >>
Powered by WorldNow

P.O. Box 8 Tulsa, OK 74101-0008

Powered by WorldNow

All content © Copyright 2000 - 2014 Worldnow and KTUL. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.